Search This Blog

Tuesday, January 9, 2024

Resmed: JP Morgan raises the target price from USD 160 to USD 195.

  maintains its overweight recommendation

https://www.marketscreener.com/quote/stock/RESMED-INC-14259/

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)